Allergies can make daily life feel like a constant battle. A stuffy nose, sneezing, and itchy eyes can ruin sleep, work, and time with family. Many people try medicines, but they do not always help enough. Now, a new look at the research points to a different option that targets a cluster of nerves in the face.
This review pulls together data from eleven clinical trials with 732 people. It focuses on a specific type of acupuncture that targets the sphenopalatine ganglion, a small bundle of nerves behind the nose. The goal is to see if this approach can help people with allergic rhinitis breathe easier and feel better.
Allergic rhinitis is very common. It affects millions of people worldwide. It happens when the immune system overreacts to things like pollen, dust, or pet dander. The result is swelling inside the nose, watery eyes, and a runny nose. Standard care often includes nasal sprays, antihistamines, or allergy shots. These can help, but some people still struggle with symptoms or side effects. That is why researchers are looking for safe, non-drug options.
But here is the twist. Acupuncture is not new. What is new is the focus on a very specific spot in the face. The sphenopalatine ganglion is a nerve hub that helps control blood flow and sensation in the nose. By stimulating this area, practitioners aim to calm the overactive response that drives allergy symptoms. This is different from traditional acupuncture points on the arms or legs.
Think of the sphenopalatine ganglion like a traffic control center for the nose. When allergies flare, the signals can get stuck in a loop, like cars circling a jam. Acupuncture at this spot may act like a traffic officer, redirecting the flow and easing the congestion. It does not remove the pollen from the air, but it may help the body react in a calmer way.
The researchers searched five major databases for studies that compared SPG acupuncture to sham acupuncture, standard medications, or regular acupuncture. They looked at quality of life scores, nasal symptom scores, and overall treatment success. They also checked for bias and graded the strength of the evidence. Most of the trials were small, and the methods varied, which is common in early research.
The results were encouraging. People who received SPG acupuncture reported better quality of life. The average improvement on the Rhinoconjunctivitis Quality of Life Questionnaire was about 7.6 points on a scale where higher scores mean worse symptoms. That difference was statistically significant, though the evidence quality was low due to variation between studies.
Nasal symptoms also improved. The Total Nasal Symptom Score, which measures sneezing, itching, runny nose, and blockage, dropped by about 2.2 points on average. Again, this was a meaningful change for patients. The evidence here was also rated as low quality, mostly because the studies were not identical in design.
Overall treatment success was higher with SPG acupuncture. About 17 percent more people saw improvement compared to control treatments. This result had moderate-quality evidence, which is stronger than the other outcomes. Importantly, the analysis did not find a change in IgE levels, the immune markers often linked to allergies. This suggests the benefit may come from a different pathway, such as nerve signaling or local blood flow.
This does not mean SPG acupuncture is widely available or covered by insurance yet.
An expert perspective from the field notes that SPG acupuncture is a promising adjunct therapy. It may fit well for patients who want to reduce medication use or who have not found relief with standard options. However, the high variation between studies means we need larger, more consistent trials before making strong recommendations.
What this means for you is practical. If you have allergic rhinitis and are curious about acupuncture, talk to your doctor and a licensed acupuncturist. Ask if SPG acupuncture is an option and what to expect. It is generally safe when performed by trained professionals, but it is not a replacement for emergency care or severe asthma.
The limitations of this review are clear. The studies were small, and the methods differed. The evidence quality ranges from low to moderate, so we cannot say this is a proven cure. More high-quality trials are needed to confirm the benefits and understand who is most likely to respond.
Looking ahead, researchers plan to run larger trials with standardized techniques. They will also explore how long the effects last and whether SPG acupuncture can be combined with other treatments. Until then, this review offers a hopeful sign that a targeted, non-drug approach may help people breathe easier and live better with allergies.